Kübra Nursel Bölük

Kübra Nursel Bölük

Auto-generated profile, based on publicly available information

Kübra Nursel Bölük

Hitit Üniversitesi

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2021 in Contact Dermatitis
Verified
Journal Article
Open access
PDF file
YEYasemin Erdem
Yasemin Erdem
SISena Inal
Sena Inal
OSOnur Sivaz
Onur Sivaz
SCSevkiye Copur
Sevkiye Copur
KBKubra N. Boluk
Kubra N. Boluk
EÖEsen Özkaya
Esen Özkaya
Background: Hand eczema (HE) has increased among healthcare workers (HCWs) working in coronavirus disease‐2019 (COVID‐19) units, and was associated with increased hand hygiene practices.Objectives: To compare the prevalence and clinical characteristics of HE, and hand hygiene practices in HCWs working in COVID‐19 and non‐COVID‐19 units.Methods: A total of 244 HCWs working in COVID‐19 (n = 118) and non‐COVID‐19 patient care units (n = 126) were examined by dermatologists with regard to demographic parameters and hand hygiene practices. The COVID‐19 and non‐COVID‐19 groups were matched at a 1:1 ratio according to age, atopy, and generalized dry skin.Results: HE was more frequent in the COVID‐19 group (48.3% vs 12.7%, P < .001), whereas working years (P < .05) and additional housework at home (P < .001) were longer in the non‐COVID‐19 group. After the development of HE, moisturizing creams were reported to be more frequently used in the COVID group (P < .001). Topical corticosteroids were used in a minority (40% in the COVID group and 26.7% in the non‐COVID group).Conclusions: HCWs in COVID‐19 units developed HE more frequently. A majority increased the frequency of moisturizer use, instead of using topical corticosteroids, after the development of HE for the purpose of treating eczema. New approaches are needed for the prevention and management of HE in HCWs, especially by facilitating access to dermatologists.

1 October 2022 in Dermatology Practical & Conceptual
Verified
Journal Article
Open access
PDF file
MKMelek Aslan Kayıran
Melek Aslan Kayıran
AKAyşe Serap Karadağ
Ayşe Serap Karadağ
ITİlTeriş Oğuz Topal
İlTeriş Oğuz Topal
SESelma Emre
Selma Emre
EAEsra Adışen
Esra Adışen
EAErkan Alpsoy
Erkan Alpsoy
Background: Due to the chronic, recurrent nature of Psoriasis vulgaris (PV) and lack of definitive treatment for the disease, patients often resort to alternative treatments. Physicians seem to have low awareness of this issue. Objectives: To elicit the perceptions of 1,621 PV patients on complementary and alternative medicine (CAM) and examine factors reported to worsen PV. Methods: The patients’ sociodemographic characteristics, Psoriasis Area Severity Index (PASI), Dermatology Life Quality Index (DLQI), disease duration, and severity were recorded, and the patients’ CAM use was questioned in detail. The patients were also asked about factors that worsened PV and their experiences with a gluten-free diet. Results: Of the patients, 56.51% had used CAM. The mean age, illness duration, PASI score,s and DLQI of those using CAM were significantly higher. CAM use were significantly higher in those with facial, genital involvement, and arthralgia/arthritis. The patients mostly referred to CAM when PV became severe (46.4%). Of the CAM users, 45.52% used herbal topicals. The physicians of 67.03% did not inquire whether they used CAM. Of the participants, 37.73% considered that stress worsened their disease. Gluten-free diet did not affect PV symptoms in 52.22%. Conclusions: Patients’ CAM use is often overlooked by dermatologists. Our results showed that more than half the patients used CAM and did not share this information with their physicians. Therefore, the awareness of physicians should be increased and patients should be asked about the use of CAM and directed to the appropriate medical treatment options by physicians.

30 August 2024 in International Journal of Dermatology
Verified
Journal Article
Closed access
KBKübra Nursel Bölük
Kübra Nursel Bölük
AKAfet Akdağ Köse
Afet Akdağ Köse

29 June 2026 in Hitit Medical Journal
Verified
Journal Article
Closed access
NYNazlı Yorulmaz
Nazlı Yorulmaz
MYMert Burak Yıldırım
Mert Burak Yıldırım
KBKübra Nursel Bölük
Kübra Nursel Bölük
AKAlpaslan Karabulut
Alpaslan Karabulut
Allopurinol reduces urate production by inhibiting xanthine oxidase. It is oxidatively hydroxylated to oxypurinol. It is the most commonly prescribed drug for the treatment of gout. Although it has a beneficial effect in the treatment of this common disease, it is also known to have numerous side effects. The most dangerous side effects associated with allopurinol use are Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN).These immune-mediated disease processes affect nearly every organ system. It is important to diagnose them as early as possible, as they can be fatal and require discontinuation of the drug at the first sign of SJS/TEN, such as a rash or other early symptoms. This case is important in terms of being careful against toxic drug reactions that may develop due to allopurinol use in elderly patients with gout.